Literature DB >> 16491410

Ceftriaxone-related hemolysis and acute renal failure.

Erkan Demirkaya1, Abdullah Avni Atay, Ugur Musabak, Ali Sengul, Faysal Gok.   

Abstract

A 5-year-old girl with no underlying immune deficiency or hematologic disease was treated with a combination of ceftriaxone and ampicilline-sulbactam for pneumonia. On the ninth day of the therapy, she developed oliguria, paleness, malaise, immune hemolytic anemia (IHA) and acute renal failure (ARF). Laboratory studies showed the presence of antibodies against ceftriaxone. Acute interstitial nephritis (AIN) was diagnosed by renal biopsy. The patient's renal insufficiency was successfully treated with peritoneal dialysis without any complications. The patient recovered without any treatment using steroids or other immunosuppressive agents.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16491410     DOI： 10.1007/s00467-006-0043-4

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN： 0931-041X            Impact factor:   3.714


  10 in total

Review 1.  Severe hemolysis induced by ceftriaxone in a child with sickle-cell anemia.

Authors:  Y Viner; P J Hashkes; R Yakubova; D Segal-Kupershmit; A S Luder
Journal:  Pediatr Infect Dis J       Date:  2000-01       Impact factor: 2.129

2.  Life-threatenting ceftriaxone-induced immune hemolytic anemia in a child with Crohn's disease.

Authors:  Lynn E Mattis; Jose M Saavedra; Hua Shan; R Sue Shirey; Eric Powell; Maria M Oliva-Hemker
Journal:  Clin Pediatr (Phila)       Date:  2004-03       Impact factor: 1.168

3.  Fatal ceftriaxone-induced hemolysis in a child with acquired immunodeficiency syndrome.

Authors:  C Borgna-Pignatti; T M Bezzi; R Reverberi
Journal:  Pediatr Infect Dis J       Date:  1995-12       Impact factor: 2.129

Review 4.  Drug-induced autoimmune hemolytic anemia.

Authors:  L D Petz
Journal:  Transfus Med Rev       Date:  1993-10

5.  Fatal immune haemolysis due to a degradation product of ceftriaxone.

Authors:  O Meyer; H Hackstein; B Hoppe; F J Göbel; G Bein; A Salama
Journal:  Br J Haematol       Date:  1999-06       Impact factor: 6.998

6.  Ceftriaxone-induced hemolytic anemia and hepatitis in an adolescent with hemoglobin SC disease.

Authors:  Michael J Bell; David C Stockwell; Naomi L C Luban; R Sue Shirey; Lorraine Shaak; Paul M Ness; Edward C C Wong
Journal:  Pediatr Crit Care Med       Date:  2005-05       Impact factor: 3.624

Review 7.  Ceftriaxone-induced immune haemolysis: two case reports and a concise review of the literature.

Authors:  A Seltsam; A Salama
Journal:  Intensive Care Med       Date:  2000-09       Impact factor: 17.440

8.  Positive direct antiglobulin tests and haemolytic anaemia following therapy with beta-lactamase inhibitor containing drugs may be associated with nonimmunologic adsorption of protein onto red blood cells.

Authors:  G Garratty; P A Arndt
Journal:  Br J Haematol       Date:  1998-03       Impact factor: 6.998

9.  Serology of antibodies to second- and third-generation cephalosporins associated with immune hemolytic anemia and/or positive direct antiglobulin tests.

Authors:  P A Arndt; R M Leger; G Garratty
Journal:  Transfusion       Date:  1999 Nov-Dec       Impact factor: 3.157

10.  Antibiotic nephrotoxicity.

Authors:  J P Morin; J P Fillastre; B Olier
Journal:  Chemioterapia       Date:  1984-02
  10 in total
  2 in total

1.  Repeated Topical Application of para-Phenylenediamine Induces Renal Histopathological Changes in Rats.

Authors:  Manuj Kr Bharali; Rajeev Basumatary; Taibur Rahman; Karabi Dutta
Journal:  Toxicol Int       Date:  2012-05

2.  Granulomatous interstitial nephritis in a patient with SARS-CoV-2 infection.

Authors:  Katarzyna Szajek; Marie-Elisabeth Kajdi; Valerie A Luyckx; Thomas Hans Fehr; Ariana Gaspert; Alexia Cusini; Karin Hohloch; Philipp Grosse
Journal:  BMC Nephrol       Date:  2021-01-08       Impact factor: 2.388
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.